FGF7 and diabetes mellitus: Moreover, miR-155 also targets fibroblast growth factor (FGF7) (also known as Keratinocyte growth factor, KGF), and by decreasing FGF7, diabetes-induced miR-155 impairs re-epithelization, while miR-155 inhibition mediates de-repression of FGF7 and accelerates wound closure (Table 2, Table 3 and Table 4) [151].